Eli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.

Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of ...

CVS Health Corp.’s drug-benefits unit negotiated a deal to make Novo Nordisk A/S’s Wegovy more widely available to its ...

Eli Lilly on Thursday posted better-than-expected quarterly results, but CVS Health's decision to drop the company's obesity ...

CVS Health's pharmacy benefits manager said weight-loss drugs from rival drugmaker Novo Nordisk will become the preferred ...

Zepbound (tirzepatide) is a once-a-week injectable weight-loss medication. It helps reduce your appetite by influencing two hormones: glucagon-like peptide-1 (GLP-1) and glucose-dependent ...

Insurance may cover Zepbound (tirzepatide) depending on your plan and specific condition. There may be ways you can get your insurance plan to cover Zepbound if it doesn’t already. The best way ...

If you’re prescribed Zepbound, your doctor or another healthcare professional will likely give you the first dose in their office. Then they’ll show you or someone else how to inject your ...

No, this isn’t some late-night infomercial fantasy — it’s the reality of Zepbound, and it’s changing everything about how we approach weight loss. While you’ve been cycling through diets ...

Zepbound is most effective when combined with a balanced diet and regular exercise. Eating plenty of filling and nutrient-dense foods can help you work toward your weight loss goals. Zepbound ...